Affiliation:
1. From the Department of Plastic and Reconstructive Surgery, CHU Charleroi, Lodelinsart, Belgium.
Abstract
Summary:
This report describes a recurrent sclerodermiform basal cell epithelioma of the malar region next to the inferior eyelid in a 57-year-old woman. Three interventions were necessary to obtain a clear margin of resection. The area of resection was closed with a local cutaneous flap. We report a rare basal cell carcinoma subtype underestimated in its aggressiveness with often inadequate medical and surgical management. This tumor, generally localized in the face, often requires aggressive surgery, and aesthetic results can be poor. The patients require close long-term follow-up even when margins are clear. General practitioners, dermatologists, and surgeons should be aware of sclerodermiform basal cell carcinoma, which is a malignant, aggressive, and recurrent tumor.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference10 articles.
1. Nonmelanoma skin cancer.;Brandt;Facial Plast Surg Clin North Am,2019
2. Good clinical practices. Diagnostic and therapeutic management of basal cell carcinoma in adults (extracts).;Rev Stomatol Chir Maxillofac,2005
3. Sclerodermiform basal cell carcinoma. Apropos of a study of 83 cases [in French].;Loddé;Ann Chir Plast Esthet,1998
4. Sclerodermiform basal cell carcinomas vs. other histotypes: analysis of specific demographic, clinical and dermatoscopic features.;Conforti;J Eur Acad Dermatol Venereol,2021
5. In vivo assessment of optical properties of basal cell carcinoma and differentiation of BCC subtypes by high-definition optical coherence tomography.;Boone;Biomed Opt Express,2016